Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Randomized, Parallel Group, Study of Efficacy and Safety of a Transdermal Contraceptive Delivery System (TCDS) in Comparison to a Low-dose Oral Contraceptive Containing 0.02 mg EE and 0.1 mg LNG in a 21-day Regimen.

NCT01181479 is registered in ClinicalTrials.gov with Agile Therapeutics as lead sponsor.

NCT NCT01181479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01181479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Randomized, Parallel Group, Study of Efficacy and Safety of a Transdermal Contraceptive Delivery System (TCDS) in Comparison to a Low-dose Oral Contraceptive Containing 0.02 mg EE and 0.1 mg LNG in a 21-day Regimen.
Lead sponsor
Agile Therapeutics
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2010
Completion date
March 31, 2012
Enrollment
1,504 (actual)
Sites
80

Conditions

As the registry lists them; a condition with its own page is linked.

contraception